PLx Pharma Winddown Corp. EBITDA
PLx Pharma Winddown Corp. EBITDA
- 2022-09-30: Basis Reported; EBITDA (m); Operating income -$10.84M; Depreciation and amortization (m).
- 2022-06-30: Basis Reported; EBITDA (m); Operating income -$14.54M; Depreciation and amortization (m).
- 2022-03-31: Basis Reported; EBITDA -$18.17M*; Operating income -$18.20M; Depreciation and amortization $30.00K.
- 2021-09-30: Basis Reported; EBITDA (m); Operating income -$9.86M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2022-09-30 | Reported | (m) | -$10.84M | (m) | (m) | (m) | (m) | (m) | (m) | $623.00K | $9.14M | $0.00 |
|---|
| 2022-06-30 | Reported | (m) | -$14.54M | (m) | (m) | (m) | (m) | (m) | (m) | $556.00K | $13.64M | $0.00 |
|---|
| 2022-03-31 | Reported | -$18.17M* | -$18.20M | $30.00K | (m) | (m) | (m) | -$16.89M | (m) | $654.00K | $18.46M | $0.00 |
|---|
| 2021-09-30 | Reported | (m) | -$9.86M | (m) | (m) | (m) | (m) | (m) | (m) | $1.55M | $11.01M | $0.00 |
|---|
| 2021-06-30 | Reported | (m) | -$6.48M | (m) | (m) | (m) | (m) | (m) | (m) | $983.00K | $5.50M | $0.00 |
|---|
| 2021-03-31 | Reported | -$3.57M* | -$3.60M | $27.00K | (m) | (m) | (m) | -$4.28M | (m) | $959.00K | $2.64M | $0.00 |
|---|
| 2020-09-30 | Reported | (m) | -$3.19M | (m) | (m) | (m) | (m) | (m) | (m) | $1.21M | $1.98M | $0.00 |
|---|
| 2020-06-30 | Reported | (m) | -$3.57M | (m) | (m) | (m) | (m) | (m) | (m) | $1.39M | $2.21M | $0.00 |
|---|
| 2020-03-31 | Reported | -$2.97M* | -$3.00M | $31.87K | (m) | (m) | $2.35K | -$3.77M | (m) | $513.91K | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$3.68M | (m) | (m) | (m) | (m) | (m) | (m) | $1.21M | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$3.85M | (m) | (m) | (m) | (m) | (m) | (m) | $1.60M | (m) | (m) |
|---|
| 2019-03-31 | Reported | -$2.86M* | -$2.92M | $55.57K | (m) | (m) | $6.89K | -$3.27M | (m) | $992.70K | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$2.80M | (m) | (m) | (m) | (m) | (m) | (m) | $1.22M | (m) | (m) |
|---|
| 2018-06-30 | Reported | (m) | -$2.40M | (m) | (m) | (m) | (m) | (m) | (m) | $734.25K | (m) | (m) |
|---|
| 2018-03-31 | Reported | -$3.20M* | -$3.24M | $34.07K | (m) | (m) | $267.32K | -$3.72M | (m) | $1.08M | (m) | (m) |
|---|
| 2017-09-30 | Reported | (m) | -$3.92M | (m) | (m) | (m) | (m) | (m) | (m) | $958.25K | (m) | (m) |
|---|
| 2017-06-30 | Reported | (m) | -$4.28M | (m) | (m) | (m) | (m) | (m) | (m) | $626.30K | (m) | -$920.00K |
|---|
| 2017-03-31 | Reported | -$1.35M* | -$1.35M | $314.00 | (m) | (m) | $72.41K | -$2.13M | (m) | $128.34K | (m) | (m) |
|---|
| 2016-09-30 | Reported | (m) | -$1.05M | (m) | (m) | (m) | (m) | (m) | (m) | $12.50K | (m) | (m) |
|---|
| 2016-06-30 | Reported | (m) | -$1.44M | (m) | (m) | (m) | (m) | (m) | (m) | $13.08K | (m) | (m) |
|---|
| 2016-03-31 | Reported | (m) | -$5.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2015-09-30 | Reported | (m) | -$5.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2015-06-30 | Reported | (m) | -$4.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2015-03-31 | Reported | (m) | -$4.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
|---|
| 2014-09-30 | Reported | (m) | -$3.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2014-06-30 | Reported | (m) | -$3.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2014-03-31 | Reported | (m) | -$2.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
|---|
| 2013-09-30 | Reported | (m) | -$990.98K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2013-06-30 | Reported | (m) | -$363.19K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2013-03-31 | Reported | (m) | -$406.59K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2021-12-31 | Reported | -$40.67M* | -$40.79M | $116.00K | (m) | (m) | (m) | -$32.12M | (m) | $4.18M | $40.01M | $0.00 |
|---|
| 2020-12-31 | Reported | -$13.33M* | -$13.46M | $125.00K | (m) | (m) | $102.00K | -$12.24M | (m) | $4.34M | $9.15M | $0.00 |
|---|
| 2019-12-31 | Reported | -$14.04M* | -$14.20M | $158.25K | (m) | (m) | $241.74K | -$12.66M | (m) | $4.74M | (m) | (m) |
|---|
| 2018-12-31 | Reported | -$10.76M* | -$10.96M | $200.96K | (m) | (m) | $654.87K | -$9.50M | (m) | $3.92M | (m) | (m) |
|---|
| 2017-12-31 | Reported | -$15.82M* | -$15.85M | $29.84K | (m) | (m) | $537.57K | -$13.31M | (m) | $4.16M | (m) | -$920.00K |
|---|
| 2016-12-31 | Reported | -$4.81M* | -$4.81M | $3.33K | (m) | (m) | (m) | -$1.81M | (m) | $78.66K | (m) | (m) |
|---|
| 2015-12-31 | Reported | (m) | -$18.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
|---|
| 2014-12-31 | Reported | (m) | -$13.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
|---|
| 2013-12-31 | Reported | (m) | -$4.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|